“Structure-Based Molecular Docking Study of a Designed Cationic Peptide Sequence KRLVAGLIRKLA Against Targeting the Extracellular Domain of HER2 in HER2-Positive Breast Cancer”. Annual Methodological Archive Research Review, vol. 4, no. 3, Mar. 2026, pp. 985-1101, https://doi.org/10.66021/.